1	En	en	SPS00	C1720294#C0332285	calificador#atributo	0-2	25_QUEST_clinical_caseMIR	SENT1	-	-
2	una	una		C0205447_1	calificador_1	3-6	25_QUEST_clinical_caseMIR	SENT1	-	-
3	mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	7-12	25_QUEST_clinical_caseMIR	SENT1	-	-
4	obesa	obeso	AQ0FS0	C0028754	hallazgo	13-18	25_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
5	de	de	SPS00	C0332285	atributo	19-21	25_QUEST_clinical_caseMIR	SENT1	-	-
6	42	42		-	-	22-24	25_QUEST_clinical_caseMIR	SENT1	-	-
7	años	año	NCMP000	C0439234	calificador	25-29	25_QUEST_clinical_caseMIR	SENT1	-	-
8	se	se	P00CN000	-	-	30-32	25_QUEST_clinical_caseMIR	SENT1	-	-
9	le	le	PP3CSD00	C1292157#C0409974	hallazgo#trastorno	33-35	25_QUEST_clinical_caseMIR	SENT1	-	-
10	realiza	realizar	VMIP3S0	-	-	36-43	25_QUEST_clinical_caseMIR	SENT1	-	-
11	determinación	determinación	NCFS000	C0242485	procedimiento	44-57	25_QUEST_clinical_caseMIR	SENT1	-	-
12	del	del	SP+DA	-	-	58-61	25_QUEST_clinical_caseMIR	SENT1	-	-
13	cortisol	cortisol	NC00SC0	C0020268	sustancia	62-70	25_QUEST_clinical_caseMIR	SENT1	-	-
14	en	en	SPS00	C1720294#C0332285	calificador#atributo	71-73	25_QUEST_clinical_caseMIR	SENT1	-	-
15	sangre	sangre	NCFS000	C0005767	sustancia	74-80	25_QUEST_clinical_caseMIR	SENT1	-	-
16	,	,	Fc	-	-	80-81	25_QUEST_clinical_caseMIR	SENT1	-	-
17	orina	orina	NCFS000	C0042036	sustancia	82-87	25_QUEST_clinical_caseMIR	SENT1	-	-
18	y	y	CC	C1706368	calificador	88-89	25_QUEST_clinical_caseMIR	SENT1	-	-
19	saliva	saliva	NCFS000	C0036087	sustancia	90-96	25_QUEST_clinical_caseMIR	SENT1	-	-
20	y	y	CC	C1706368	calificador	97-98	25_QUEST_clinical_caseMIR	SENT1	-	-
21	en	en	SPS00	C1720294#C0332285	calificador#atributo	99-101	25_QUEST_clinical_caseMIR	SENT1	-	-
22	todas	todo	DI0FP0	C0205197#C0439810#C0444868#C0444667	calificador	102-107	25_QUEST_clinical_caseMIR	SENT1	-	-
23	las	el	DA0FP0	-	-	108-111	25_QUEST_clinical_caseMIR	SENT1	-	-
24	determinaciones	determinación	NCFP000	C0242485	procedimiento	112-127	25_QUEST_clinical_caseMIR	SENT1	-	-
25	está	estar	VAIP3S0	-	-	128-132	25_QUEST_clinical_caseMIR	SENT1	-	-
26	elevado	elevar	VMP00SM	-	-	133-140	25_QUEST_clinical_caseMIR	SENT1	-	-
27	.	.	Fp	-	-	140-141	25_QUEST_clinical_caseMIR	SENT1	-	-

1	Tras	tras	SPS00	-	-	142-146	25_QUEST_clinical_caseMIR	SENT2	-	-
2	la	el	DA0FS0	-	-	147-149	25_QUEST_clinical_caseMIR	SENT2	-	-
3	realización	realización	NCFS000	-	-	150-161	25_QUEST_clinical_caseMIR	SENT2	-	-
4	del	del	SP+DA	-	-	162-165	25_QUEST_clinical_caseMIR	SENT2	-	-
5	test	test	NCMS000	-	-	166-170	25_QUEST_clinical_caseMIR	SENT2	-	-
6	de	de	SPS00	C0332285	atributo	171-173	25_QUEST_clinical_caseMIR	SENT2	-	-
7	supresión	supresión	NCFS000	-	-	174-183	25_QUEST_clinical_caseMIR	SENT2	-	-
8	nocturna	nocturno	AQ0FS0	C0240526	calificador	184-192	25_QUEST_clinical_caseMIR	SENT2	-	-
9	con	con	SPS00	C0332287	atributo	193-196	25_QUEST_clinical_caseMIR	SENT2	-	-
10	dexametasona	dexametasona	NC00SC0	C0011777	producto#sustancia	197-209	25_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
11	,	,	Fc	-	-	209-210	25_QUEST_clinical_caseMIR	SENT2	-	-
12	los	el	DA0MP0	-	-	211-214	25_QUEST_clinical_caseMIR	SENT2	-	-
13	niveles	nivel	NCMP000	C0456079	atributo	215-222	25_QUEST_clinical_caseMIR	SENT2	-	-
14	de	de	SPS00	C0332285	atributo	223-225	25_QUEST_clinical_caseMIR	SENT2	-	-
15	cortisol	cortisol	NC00SC0	C0020268	sustancia	226-234	25_QUEST_clinical_caseMIR	SENT2	-	-
16	en	en	SPS00	C1720294#C0332285	calificador#atributo	235-237	25_QUEST_clinical_caseMIR	SENT2	-	-
17	sangre	sangre	NCFS000	C0005767	sustancia	238-244	25_QUEST_clinical_caseMIR	SENT2	-	-
18	permanecen	permanecer	VMIP3P0	-	-	245-255	25_QUEST_clinical_caseMIR	SENT2	-	-
19	elevados	elevar	VMP00PM	-	-	256-264	25_QUEST_clinical_caseMIR	SENT2	-	-
20	,	,	Fc	-	-	264-265	25_QUEST_clinical_caseMIR	SENT2	-	-
21	por	por	SPS00	C0678226	atributo	266-269	25_QUEST_clinical_caseMIR	SENT2	-	-
22	lo	el	DA0NS0	-	-	270-272	25_QUEST_clinical_caseMIR	SENT2	-	-
23	que	que	PR0CN000	-	-	273-276	25_QUEST_clinical_caseMIR	SENT2	-	-
24	se	se	P00CN000	-	-	277-279	25_QUEST_clinical_caseMIR	SENT2	-	-
25	sospecha	sospechar	VMIP3S0	-	-	280-288	25_QUEST_clinical_caseMIR	SENT2	-	-
26	síndrome	síndrome	NCMS000	C0001622#C0010481_1	trastorno_1	289-297	25_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	Especulacion
27	de	de	SPS00	C0001622#C0010481_2	trastorno_2	298-300	25_QUEST_clinical_caseMIR	SENT2	I-Grp_Enfermedad	-
28	Cushing	Cushing		C0001622#C0010481_3	trastorno_3	301-308	25_QUEST_clinical_caseMIR	SENT2	I-Grp_Enfermedad	-
29	ACTH	adrenocorticotrophic_hormone_(hormona_adrenocorticotropa)	NC00YL0	-	-	309-313	25_QUEST_clinical_caseMIR	SENT2	I-Grp_Enfermedad	-
30	independiente	independiente	AQ0CS0	C1299583	calificador	314-327	25_QUEST_clinical_caseMIR	SENT2	-	-
31	,	,	Fc	-	-	327-328	25_QUEST_clinical_caseMIR	SENT2	-	-
32	.	.	Fp	-	-	329-330	25_QUEST_clinical_caseMIR	SENT2	-	-
33	qué	qué	DT0CN0	-	-	331-334	25_QUEST_clinical_caseMIR	SENT2	-	-
34	prueba	prueba	NCFS000	-	-	335-341	25_QUEST_clinical_caseMIR	SENT2	-	-
35	adicional	adicional	AQ0CS0	-	-	342-351	25_QUEST_clinical_caseMIR	SENT2	-	-
36	solicitaría	solicitar	VMIC3S0	-	-	352-363	25_QUEST_clinical_caseMIR	SENT2	-	-
37	para	para	SPS00	C0521125	calificador	364-368	25_QUEST_clinical_caseMIR	SENT2	-	-
38	confirmar	confirmar	VMN0000	-	-	369-378	25_QUEST_clinical_caseMIR	SENT2	-	-
39	el	el	DA0MS0	-	-	379-381	25_QUEST_clinical_caseMIR	SENT2	-	-
40	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	382-393	25_QUEST_clinical_caseMIR	SENT2	-	-
41	en	en	SPS00	C1720294#C0332285	calificador#atributo	394-396	25_QUEST_clinical_caseMIR	SENT2	-	-
42	este	este	DD0MS0	-	-	397-401	25_QUEST_clinical_caseMIR	SENT2	-	-
43	momento	momento	NCMS000	C0040223#C0563597	calificador#fuerza_física	402-409	25_QUEST_clinical_caseMIR	SENT2	-	-
44	.	.	Fp	-	-	409-410	25_QUEST_clinical_caseMIR	SENT2	-	-

